凯立新材(688269) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 reached ¥62,576.34 million, a 105.25% increase compared to ¥30,487.45 million in the same period last year[2] - Net profit attributable to shareholders was ¥2,189.96 million, reflecting a 90.48% growth from ¥1,149.69 million year-on-year[2] - The net profit excluding non-recurring gains and losses was ¥2,367.00 million, up 187.34% from ¥823.77 million in the previous year[2] - The basic earnings per share increased to ¥0.17, an 88.89% rise from ¥0.09 in the same period last year[2] - Total operating revenue for Q1 2025 reached ¥625,763,432.30, a significant increase of 104.5% compared to ¥304,874,534.07 in Q1 2024[14] - Operating profit for Q1 2025 was ¥23,292,953.92, up from ¥12,835,851.24 in Q1 2024, reflecting an increase of 81.5%[15] - Net profit for Q1 2025 was ¥21,873,154.57, compared to ¥11,496,246.93 in Q1 2024, representing an increase of 90.9%[15] - Basic and diluted earnings per share for Q1 2025 were both ¥0.17, up from ¥0.09 in Q1 2024, indicating an increase of 88.9%[16] - The company reported a total comprehensive income of ¥21,077,174.53 for Q1 2025, compared to ¥10,819,184.22 in Q1 2024, an increase of 94.5%[16] Revenue Drivers - The company's catalyst product sales volume increased by 188.87%, significantly contributing to revenue growth, particularly in the pharmaceutical and basic chemical sectors, which saw increases of 174.88% and 285.60% respectively[5] Cash Flow and Liquidity - The company reported a net cash flow from operating activities of -¥19,906.09 million, compared to -¥4,475.64 million in the same period last year[2] - Cash inflow from operating activities in Q1 2025 was ¥451,123,861.73, compared to ¥241,657,569.50 in Q1 2024, marking an increase of 86.6%[18] - Operating cash flow out totaled approximately $650.18 million, compared to $286.41 million in the previous period[19] - Cash generated from operating activities was negative at approximately -$199.06 million, worsening from -$44.76 million[19] - The net increase in cash and cash equivalents was approximately -$172.41 million, compared to -$103.13 million in the previous period[20] - The ending balance of cash and cash equivalents was approximately $129.26 million, down from $212.79 million[20] Expenses and Investments - Research and development expenses totaled ¥1,182.78 million, accounting for 1.89% of revenue, down from 3.76% in the previous year[3] - Research and development expenses for Q1 2025 were ¥11,827,836.72, slightly up from ¥11,456,856.40 in Q1 2024, indicating a focus on innovation[14] - The financial expenses for Q1 2025 were ¥3,194,546.53, significantly higher than ¥577,106.64 in Q1 2024, primarily due to increased interest expenses[14] - Investment cash inflow was $9,223.39, while cash outflow for investments was $48.51 million, leading to a net cash flow from investment activities of approximately -$48.50 million[19] Assets and Liabilities - The total assets at the end of the reporting period were ¥210,013.29 million, a 2.38% increase from ¥205,134.08 million at the end of the previous year[3] - As of March 31, 2025, total assets amounted to RMB 2,100,132,947.98, an increase from RMB 2,051,340,758.70 as of December 31, 2024, reflecting a growth of approximately 2.4%[11] - Current assets totaled RMB 1,001,077,382.48, compared to RMB 983,178,589.55 at the end of 2024, indicating an increase of about 1.0%[11] - Total liabilities increased to RMB 1,053,176,865.29 from RMB 999,321,050.54, reflecting a growth of approximately 5.4%[13] - Short-term borrowings rose to RMB 561,605,298.22 from RMB 463,446,262.77, an increase of about 21.2%[12] - Non-current assets totaled RMB 1,099,055,565.50, up from RMB 1,068,162,169.15, indicating an increase of approximately 2.9%[12] - The company's equity attributable to shareholders decreased slightly to RMB 1,008,447,933.26 from RMB 1,013,485,099.31, a decline of about 0.5%[13] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 5,978[6] - The company reported no significant changes in the participation of major shareholders in margin financing and securities lending activities[10] Future Outlook - The company plans to implement new accounting standards starting in 2025, which may affect financial reporting[20]